Physician offices could one day have a point-of-care gonorrhea test that not only delivers results within 30 minutes but also indicates the infecting strain’s susceptibility to ciprofloxacin. In August, San Jose, California, startup Visby Medical, Inc won a $19 million federal prize to develop its prototype device, which could help thwart antimicrobial resistance by reducing unnecessary antibiotic use.
Abbasi J. Antibiotic-Sparing Gonorrhea Diagnostic Wins Federal Funding. JAMA. 2020;324(10):928. doi:10.1001/jama.2020.16465
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: